Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma.

Chang KP, Kao HK, Wu CC, Fang KH, Chang YL, Huang YC, Liu SC, Cheng MH.

Otolaryngol Head Neck Surg. 2013 May;148(5):786-91. doi: 10.1177/0194599813478573. Epub 2013 Feb 20.

PMID:
23426713
2.

Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.

Chang KP, Wu CC, Fang KH, Tsai CY, Chang YL, Liu SC, Kao HK.

Oral Oncol. 2013 Aug;49(8):802-7. doi: 10.1016/j.oraloncology.2013.05.006. Epub 2013 Jun 12.

PMID:
23769451
3.

Interleukin-6 predicts recurrence and survival among head and neck cancer patients.

Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN.

Cancer. 2008 Aug 15;113(4):750-7. doi: 10.1002/cncr.23615.

4.

Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.

Chang KP, Chang YT, Liao CT, Yen TC, Chen IH, Chang YL, Liu YL, Chang YS, Yu JS, Wu CC.

Clin Chim Acta. 2011 May 12;412(11-12):980-7. doi: 10.1016/j.cca.2011.02.002. Epub 2011 Feb 21.

PMID:
21315702
5.

Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.

Preti HA, Cabanillas F, Talpaz M, Tucker SL, Seymour JF, Kurzrock R.

Ann Intern Med. 1997 Aug 1;127(3):186-94.

PMID:
9245223
6.

Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.

Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG.

Head Neck. 2002 Nov;24(11):1004-11.

7.

Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.

Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH.

Ann Surg Oncol. 2012 Nov;19(12):3856-64. doi: 10.1245/s10434-012-2392-5. Epub 2012 May 11.

PMID:
22576068
8.

The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.

Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT, Yen TC.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e223-30. doi: 10.1016/j.ijrobp.2011.03.060. Epub 2011 Jun 2.

PMID:
21640500
9.

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.

10.

Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY.

Am J Surg Pathol. 2005 Feb;29(2):167-78.

PMID:
15644773
11.

Histological pattern of mandibular invasion by oral squamous cell carcinoma.

Wong RJ, Keel SB, Glynn RJ, Varvares MA.

Laryngoscope. 2000 Jan;110(1):65-72.

PMID:
10646718
12.
13.

Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison.

de Sampaio Góes FC, Oliveira DT, Dorta RG, Nishimoto IN, Landman G, Kowalski LP.

Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):83-6.

PMID:
14732774
14.

Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.

Porrini R, Vercellino V, Rocchetti V, Renò F, Giorda E, Pomato E, Cannas M, Sabbatini M.

Minerva Stomatol. 2010 May;59(5):233-9, 239-43. English, Italian.

PMID:
20502428
15.

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.

Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.

Cancer. 2001 Oct 1;92(7):1896-904.

PMID:
11745263
16.

Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study.

Wu CH, Wu TY, Li CC, Lui MT, Chang KW, Kao SY.

Ann Surg Oncol. 2010 Aug;17(8):2175-83. doi: 10.1245/s10434-010-0996-1. Epub 2010 Mar 12.

PMID:
20224856
17.

Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.

Hao W, Zhu Y, Zhou H.

Med Oncol. 2013 Mar;30(1):333. doi: 10.1007/s12032-012-0333-6. Epub 2012 Dec 27.

PMID:
23269580
18.

Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.

Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC.

Cancer. 2007 Aug 1;110(3):564-71.

19.

Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.

Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, Hsueh C, Chen IH, Huang SF, Kang CJ, Yen TC.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):284-90. doi: 10.1016/j.ijrobp.2010.09.036. Epub 2010 Nov 13.

PMID:
21075550
20.

Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.

Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH, Patel PS.

Oral Dis. 2003 May;9(3):119-28.

PMID:
12945593

Supplemental Content

Support Center